{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:13:09Z","timestamp":1778998389897,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T00:00:00Z","timestamp":1437004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s10689-015-9823-y","type":"journal-article","created":{"date-parts":[[2015,7,15]],"date-time":"2015-07-15T09:55:37Z","timestamp":1436954137000},"page":"521-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK"],"prefix":"10.1007","volume":"14","author":[{"given":"Dhivya","family":"Chandrasekaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertan","family":"Saridogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Tischkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elly","family":"Brockbank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatinder","family":"Kalsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davor","family":"Jurkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjit","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,16]]},"reference":[{"key":"9823_CR1","unstructured":"CRUK (2014) Ovarian cancer, key stats. Cancer statistics. Nov 2014 ed. CRUK: Cancer Research, UK pp 1\u20132. http:\/\/publications.cancerresearchuk.org\/downloads\/Product\/CS_KF_OVARY.pdf"},{"issue":"7353","key":"9823_CR2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Integrated genomic analyses of ovarian carcinoma","year":"2011","unstructured":"Integrated genomic analyses of ovarian carcinoma (2011) Nature 474(7353):609\u2013615","journal-title":"Nature"},{"issue":"21","key":"9823_CR3","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","volume":"30","author":"K Alsop","year":"2012","unstructured":"Alsop K, Fereday S, Meldrum C et al (2012) BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 30(21):2654\u20132663","journal-title":"J Clin Oncol"},{"issue":"12","key":"9823_CR4","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","volume":"104","author":"T Pal","year":"2005","unstructured":"Pal T, Permuth-Wey J, Betts JA et al (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104(12):2807\u20132816","journal-title":"Cancer"},{"issue":"3","key":"9823_CR5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-13-2287","volume":"20","author":"KP Pennington","year":"2014","unstructured":"Pennington KP, Walsh T, Harrell MI et al (2014) Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res 20(3):764\u2013775","journal-title":"Clin Cancer Res"},{"issue":"44","key":"9823_CR6","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK et al (2011) Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci USA 108(44):18032\u201318037","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"9823_CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","volume":"121","author":"S Zhang","year":"2011","unstructured":"Zhang S, Royer R, Li S et al (2011) Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 121(2):353\u2013357","journal-title":"Gynecol Oncol"},{"issue":"5","key":"9823_CR8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"11","key":"9823_CR9","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329\u20131333","journal-title":"J Clin Oncol"},{"issue":"11","key":"9823_CR10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812\u2013822","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"9823_CR11","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2005.03.6772","volume":"24","author":"S Chen","year":"2006","unstructured":"Chen S, Iversen ES, Friebel T et al (2006) Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 24(6):863\u2013871","journal-title":"J Clin Oncol"},{"issue":"5645","key":"9823_CR12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646","journal-title":"Science"},{"issue":"11","key":"9823_CR13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.ejhg.5201256","volume":"12","author":"F Marroni","year":"2004","unstructured":"Marroni F, Aretini P, D\u2019Andrea E et al (2004) Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1\/2 mutations. Eur J Hum Genet 12(11):899\u2013906","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"9823_CR14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00008469-200508000-00008","volume":"14","author":"G Rennert","year":"2005","unstructured":"Rennert G, Dishon S, Rennert HS, Fares F (2005) Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel. Eur J Cancer Prev 14(4):357\u2013361","journal-title":"Eur J Cancer Prev"},{"key":"9823_CR15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2407-8-155","volume":"8","author":"DG Evans","year":"2008","unstructured":"Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER (2008) Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a clinical cancer genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family. BMC Cancer 8:155","journal-title":"BMC Cancer"},{"issue":"24","key":"9823_CR16","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1200\/JCO.2005.03.909","volume":"23","author":"I Jacobs","year":"2005","unstructured":"Jacobs I (2005) Screening for familial ovarian cancer: the need for well-designed prospective studies. J Clin Oncol 23(24):5443\u20135445","journal-title":"J Clin Oncol"},{"issue":"9","key":"9823_CR17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/jmg.2008.058248","volume":"46","author":"DG Evans","year":"2009","unstructured":"Evans DG, Gaarenstroom KN, Stirling D et al (2009) Screening for familial ovarian cancer: poor survival of BRCA1\/2 related cancers. J Med Genet 46(9):593\u2013597","journal-title":"J Med Genet"},{"issue":"9","key":"9823_CR18","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","volume":"96","author":"BB Hermsen","year":"2007","unstructured":"Hermsen BB, Olivier RI, Verheijen RH et al (2007) No efficacy of annual gynaecological screening in BRCA1\/2 mutation carriers; an observational follow-up study. Br J Cancer 96(9):1335\u20131342","journal-title":"Br J Cancer"},{"issue":"2","key":"9823_CR19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","volume":"101","author":"TR Rebbeck","year":"2009","unstructured":"Rebbeck TR, Kauff ND, Domchek SM (2009) Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst 101(2):80\u201387","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"9823_CR20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.maturitas.2005.04.009","volume":"53","author":"E Lokkegaard","year":"2006","unstructured":"Lokkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT (2006) The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas 53(2):226\u2013233","journal-title":"Maturitas"},{"issue":"1","key":"9823_CR21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","volume":"16","author":"CM Rivera","year":"2009","unstructured":"Rivera CM, Grossardt BR, Rhodes DJ et al (2009) Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 16(1):15\u201323","journal-title":"Menopause"},{"issue":"1","key":"9823_CR22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejca.2008.09.028","volume":"45","author":"TM Michelsen","year":"2009","unstructured":"Michelsen TM, Pripp AH, Tonstad S, Trope CG, Dorum A (2009) Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. Eur J Cancer 45(1):82\u201389","journal-title":"Eur J Cancer"},{"issue":"1","key":"9823_CR23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000211951","volume":"33","author":"CM Rivera","year":"2009","unstructured":"Rivera CM, Grossardt BR, Rhodes DJ, Rocca WA (2009) Increased mortality for neurological and mental diseases following early bilateral oophorectomy. Neuroepidemiology 33(1):32\u201340","journal-title":"Neuroepidemiology"},{"issue":"11","key":"9823_CR24","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","volume":"69","author":"WA Rocca","year":"2007","unstructured":"Rocca WA, Bower JH, Maraganore DM et al (2007) Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69(11):1074\u20131083","journal-title":"Neurology"},{"issue":"3","key":"9823_CR25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1212\/01.wnl.0000280573.30975.6a","volume":"70","author":"WA Rocca","year":"2008","unstructured":"Rocca WA, Bower JH, Maraganore DM et al (2008) Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology 70(3):200\u2013209","journal-title":"Neurology"},{"issue":"28","key":"9823_CR26","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","volume":"23","author":"JB Madalinska","year":"2005","unstructured":"Madalinska JB, Hollenstein J, Bleiker E et al (2005) Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 23(28):6890\u20136898","journal-title":"J Clin Oncol"},{"issue":"22","key":"9823_CR27","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","volume":"24","author":"JB Madalinska","year":"2006","unstructured":"Madalinska JB, van Beurden M, Bleiker EM et al (2006) The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 24(22):3576\u20133582","journal-title":"J Clin Oncol"},{"issue":"10","key":"9823_CR28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","volume":"7","author":"WA Rocca","year":"2006","unstructured":"Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd (2006) Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol 7(10):821\u2013828","journal-title":"Lancet Oncol"},{"issue":"5","key":"9823_CR29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-0528.2011.03257.x","volume":"119","author":"R Manchanda","year":"2012","unstructured":"Manchanda R, Burnell M, Abdelraheim A et al (2012) Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis. BJOG 119(5):527\u2013536","journal-title":"BJOG"},{"issue":"1","key":"9823_CR30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","volume":"5","author":"CP Crum","year":"2007","unstructured":"Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y (2007) Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res 5(1):35\u201344","journal-title":"Clin Med Res"},{"issue":"11","key":"9823_CR31","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/humrep\/der274","volume":"26","author":"J Dietl","year":"2011","unstructured":"Dietl J, Wischhusen J, Hausler SF (2011) The post-reproductive fallopian tube: better removed? Hum Reprod 26(11):2918\u20132924","journal-title":"Hum Reprod"},{"issue":"3","key":"9823_CR32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2011.02.012","volume":"121","author":"E Leblanc","year":"2011","unstructured":"Leblanc E, Narducci F, Farre I et al (2011) Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? rationale and preliminary development. Gynecol Oncol 121(3):472\u2013476","journal-title":"Gynecol Oncol"},{"key":"9823_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gynor.2014.03.003","volume":"9","author":"SH Kim","year":"2014","unstructured":"Kim SH, Frey MK, Blank SV (2014) Occult tubal carcinoma found at risk reducing salpingectomy in a BRCA1 carrier. Gynecol Oncol Rep 9:1\u20132","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"9823_CR34","doi-asserted-by":"crossref","first-page":"19 e1","DOI":"10.1016\/j.ajog.2010.05.038","volume":"204","author":"MH Greene","year":"2011","unstructured":"Greene MH, Mai PL, Schwartz PE (2011) Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1\/2 mutation carriers? Am J Obstet Gynecol 204(1):19 e1\u201319 e6","journal-title":"Am J Obstet Gynecol"},{"key":"9823_CR35","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1158\/1078-0432.CCR-09-2953","volume":"16","author":"SM Miller","year":"2010","unstructured":"Miller SM, Roussi P, Daly MB, Scarpato J (2010) New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy. Clin Cancer Res 16:5094\u20135106","journal-title":"Clin Cancer Res"},{"issue":"9","key":"9823_CR36","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA, J Am Med Assoc 304(9):967\u2013975","journal-title":"JAMA, J Am Med Assoc"},{"key":"9823_CR37","doi-asserted-by":"crossref","unstructured":"Heemskerk-Gerritsen BA, Seynaeve C, van Asperen CJ, et al.(2015) Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction. J Natl Cancer Inst 107(5). doi: 10.1093\/jnci\/djv033","DOI":"10.1093\/jnci\/djv033"},{"issue":"8","key":"9823_CR38","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","volume":"26","author":"ND Kauff","year":"2008","unstructured":"Kauff ND, Domchek SM, Friebel TM et al (2008) Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 26(8):1331\u20131337","journal-title":"J Clin Oncol"},{"issue":"30","key":"9823_CR39","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","volume":"23","author":"A Eisen","year":"2005","unstructured":"Eisen A, Lubinski J, Klijn J et al (2005) Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol 23(30):7491\u20137496","journal-title":"J Clin Oncol"},{"issue":"7","key":"9823_CR40","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/jmg.2004.024133","volume":"42","author":"AC Antoniou","year":"2005","unstructured":"Antoniou AC, Pharoah PD, Narod S et al (2005) Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 42(7):602\u2013603","journal-title":"J Med Genet"},{"issue":"1","key":"9823_CR41","first-page":"265","volume":"56","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. breast cancer linkage consortium. Am J Hum Genet 56(1):265\u2013271","journal-title":"Am J Hum Genet"},{"issue":"3","key":"9823_CR42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. the breast cancer linkage consortium. Am J Hum Genet 62(3):676\u2013689","journal-title":"Am J Hum Genet"},{"issue":"2","key":"9823_CR43","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ygyno.2014.12.031","volume":"136","author":"M Arts-de Jong","year":"2015","unstructured":"Arts-de Jong M, Harmsen MG, Hoogerbrugge N, Massuger LF, Hermens RP, de Hullu JA (2015) Risk-reducing salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: patients\u2019 and professionals\u2019 perspectives. Gynecol Oncol 136(2):305\u2013310","journal-title":"Gynecol Oncol"},{"issue":"2","key":"9823_CR44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","volume":"133","author":"LL Holman","year":"2014","unstructured":"Holman LL, Friedman S, Daniels MS, Sun CC, Lu KH (2014) Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers. Gynecol Oncol 133(2):283\u2013286","journal-title":"Gynecol Oncol"},{"issue":"7440","key":"9823_CR45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature11979","volume":"495","author":"A Flesken-Nikitin","year":"2013","unstructured":"Flesken-Nikitin A, Hwang CI, Cheng CY, Michurina TV, Enikolopov G, Nikitin AY (2013) Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche. Nature 495(7440):241\u2013245","journal-title":"Nature"},{"issue":"12","key":"9823_CR46","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","volume":"9","author":"L Dubeau","year":"2008","unstructured":"Dubeau L (2008) The cell of origin of ovarian epithelial tumours. Lancet Oncol 9(12):1191\u20131197","journal-title":"Lancet Oncol"},{"issue":"2","key":"9823_CR47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2014.01.018","volume":"132","author":"CB Powell","year":"2014","unstructured":"Powell CB (2014) Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later. Gynecol Oncol 132(2):261\u2013263","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9823_CR48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","volume":"121","author":"JS Kwon","year":"2013","unstructured":"Kwon JS, Tinker A, Pansegrau G et al (2013) Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers. Obstet Gynecol 121(1):14\u201324","journal-title":"Obstet Gynecol"},{"issue":"1","key":"9823_CR49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10549-009-0373-6","volume":"119","author":"VR Grann","year":"2010","unstructured":"Grann VR, Patel P, Bharthuar A et al (2010) Breast cancer-related preferences among women with and without BRCA mutations. Breast Cancer Res Treat 119(1):177\u2013184","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"9823_CR50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1200\/JCO.2006.09.2437","volume":"25","author":"D Schrag","year":"2007","unstructured":"Schrag D, Hanger M (2007) Medical oncologists\u2019 views on communicating with patients about chemotherapy costs: a pilot survey. J Clin Oncol 25(2):233\u2013237","journal-title":"J Clin Oncol"},{"issue":"10","key":"9823_CR51","first-page":"1424","volume":"54","author":"I Grava-Gubins","year":"2008","unstructured":"Grava-Gubins I, Scott S (2008) Effects of various methodologic strategies: survey response rates among Canadian physicians and physicians-in-training. Can Fam Physician 54(10):1424\u20131430","journal-title":"Can Fam Physician"},{"issue":"3","key":"9823_CR52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1370\/afm.944","volume":"7","author":"PJ Kroth","year":"2009","unstructured":"Kroth PJ, McPherson L, Leverence R (2009) Combining web-based and mail surveys improves response rates: a PBRN study from PRIME Net. Ann Fam Med 7(3):245\u2013248","journal-title":"Ann Fam Med"},{"issue":"4","key":"9823_CR53","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.2196\/jmir.6.4.e39","volume":"6","author":"P Leece","year":"2004","unstructured":"Leece P, Bhandari M, Sprague S et al (2004) Internet versus mailed questionnaires: a controlled comparison (2). J Med Internet Res 6(4):e39","journal-title":"J Med Internet Res"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-015-9823-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-015-9823-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-015-9823-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T07:42:46Z","timestamp":1566978166000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-015-9823-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,16]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9823"],"URL":"https:\/\/doi.org\/10.1007\/s10689-015-9823-y","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,16]]}}}